Evidence map›Paper›PMID 41691141›Full record

ArticleEJNMMI research2026

Diagnostic value and interpretability of [

Paola Anna Erba, Roberta Zanca, Martina Sollini, Lara Cavinato, Alessandra Ragni, Derk Ten Hove, Andor Wjm Glaudemans, Santiago Aguadè-Bruix, Maria N Pizzi, Albert Roque and 2 more

Abstract read
In one paragraph

Article in EJNMMI research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Paola Anna ErbaDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. paolaanna.erba@unimib.it.
Roberta ZancaDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele (Milan), Italy.
Martina SolliniFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milano, Italy.
Lara CavinatoDepartment of Mathematics, MOX, Politecnico di Milano, Piazza Leonardo da Vinci 32, Milano, 20133, Italy.
Alessandra RagniDepartment of Mathematics, MOX, Politecnico di Milano, Piazza Leonardo da Vinci 32, Milano, 20133, Italy.
Derk Ten HoveMedical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Andor Wjm GlaudemansMedical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Santiago Aguadè-BruixUniversitat Autònoma de Barcelona, Barcelona, Spain.
Maria N PizziUniversitat Autònoma de Barcelona, Barcelona, Spain.
Albert RoqueUniversitat Autònoma de Barcelona, Barcelona, Spain.
Francesca IevaDepartment of Mathematics, MOX, Politecnico di Milano, Piazza Leonardo da Vinci 32, Milano, 20133, Italy.
Riemer Hja SlartMedical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundto assess the value of [18 F]FDG PET/CT radiomics in infective endocarditis (IE) diagnosis. We evaluated and collected [18 F]FDG PET/CT and clinical data of 447 patients, with suspected IE studied in 3 centers. Radiomic features were calculated and after dimensionality reduction, we performed: (1) univariate testing for assessing the discrimination power of clinical variables and radiomics; (2) a multivariate random forest-based model fed by radiomics to predict the outcome of PET/CT visual analysis; (3) a clustering-based radiomic model to predict final diagnosis; (4) a series of Logistic Regression (LR) models to assess the relative contribution of each criterion in relation with final diagnosis.

results9/17 clinical and 7/11 radiomics variables were able to univariately stratify patients. The random forest model accurately predicted PET/CT visual assessment in definite cases, providing a classification of doubtful cases resembling the “IE-negative” radiomic signature. The clustering-based analysis divided patients in two groups. LRs demonstrated that the richer the information fed into the model, the higher the performances: the models including radiomics performed better than the one solely including visual image assessment.

conclusionRadiomic signature, employing both supervised and unsupervised approaches, effectively described and differentiated [18 F]FDG PET/CT outcomes in a large IE cohort. The identification of specific signatures for equivocal PET/CT findings suggests that radiomic features can assist in interpreting ambiguous PET results, thus significantly impacting patient management. Clustering algorithm successfully associated patients with varying conditions, allowing for further assessment and characterization within the radiomics framework, potentially leading to risk score-based interpretations.

Identifiers

PMID41691141
PMCPMC12913809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.